Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)

NCT02339155 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT02339155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02339155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
Lead sponsor
Emergent BioSolutions
Phase
Phase 4
Overall status
Completed
Start date
February 24, 2015
Completion date
June 6, 2017
Enrollment
573 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infections, bacterial